| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
1 company
Welgus Howard G. is a Director at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $989K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 10,000 | $8.01 | $80,091.70 | -2.8% | +33.2% | +68.4% | |
| Apr 17, 2023 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 8,500 | $13.97 | $118,728.00 | -4.9% | -21.5% | -27.8% | |
| Apr 6, 2023 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 8,500 | $12.01 | $102,085.00 | -4.9% | -22.8% | -5.7% | |
| Feb 15, 2023 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 8,500 | $16.98 | $144,352.10 | -4.9% | -41.8% | -53.5% | |
| Jan 17, 2023 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 8,500 | $13.72 | $116,654.85 | -4.9% | -4.7% | -77.2% | |
| Nov 15, 2022 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 3,403 | $20.01 | $68,102.54 | -2.0% | -13.4% | -89.3% | |
| Oct 4, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 6,000 | $20.29 | $121,766.40 | -3.4% | -27.6% | -77.9% | |
| Aug 15, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 6,000 | $24.80 | $148,788.60 | -3.3% | -24.3% | -65.7% | |
| Jul 18, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 6,000 | $24.40 | $146,373.60 | -3.2% | -18.2% | -55.3% | |
| Jun 1, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sale+OE | 2,500 | $20.62 | $51,538.50 | -1.4% | +27.2% | -62.3% |